ProfileGDS5822 / ILMN_2471770
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 39% 35% 36% 1% 19% 3% 11% 24% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.939
GSM1276600PDAC Late Ablation Control 218.735
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 11536
GSM1276603PDAC Late Ablation 22.51
GSM1276604PDAC Late Ablation 311.719
GSM1303940PDAC Late Ablation_anti-CTLA4 16.13
GSM1303941PDAC Late Ablation_anti-CTLA4 27.511
GSM1303942PDAC Late Ablation_anti-CTLA4 312.424